Translation
Jul 26, 2018
| Name of listed company: |
|
Chugai Pharmaceutical Co., Ltd. |
| Code number: |
4519 (1st Section of Tokyo Stock Exchange) |
| Head office: |
1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: |
Tatsuro Kosaka |
| Inquiries to: |
Masahiko Uchida,
General Manager, Corporate Communications Dept. |
| |
Tel:+81-(0)3-3273-0881 |
F. Hoffmann-La Roche Announces Half Year Results 2018
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its half year results 2018 (January 1 – June 30, 2018).
Roche owns 59.89% of Chugai’s outstanding shares (61.27% of the total number of shares issued excluding treasury stock) as of end of June 2018.
Its press release and presentation materials can be found on its website (https://www.roche.com).
Chugai’s performance for the period of January 1 to June 30, 2018 is included in the announced Roche Group’s results.
